Intchains Group (NASDAQ:ICG – Get Free Report) and Ainos (NASDAQ:AIMD – Get Free Report) are both small-cap technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.
Risk & Volatility
Intchains Group has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Ainos has a beta of 2.47, indicating that its stock price is 147% more volatile than the S&P 500.
Profitability
This table compares Intchains Group and Ainos’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intchains Group | -24.68% | -5.29% | -5.08% |
| Ainos | -11,912.10% | -217.50% | -67.87% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intchains Group | $31.58 million | 1.78 | -$6.80 million | ($0.12) | -7.71 |
| Ainos | $13,600.00 | 808.98 | -$14.77 million | ($2.52) | -0.59 |
Intchains Group has higher revenue and earnings than Ainos. Intchains Group is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Intchains Group and Ainos, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intchains Group | 1 | 1 | 2 | 0 | 2.25 |
| Ainos | 1 | 0 | 0 | 0 | 1.00 |
Intchains Group currently has a consensus price target of $2.50, suggesting a potential upside of 170.27%. Given Intchains Group’s stronger consensus rating and higher possible upside, equities analysts clearly believe Intchains Group is more favorable than Ainos.
Summary
Intchains Group beats Ainos on 9 of the 12 factors compared between the two stocks.
About Intchains Group
Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China.
About Ainos
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women’s health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Receive News & Ratings for Intchains Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intchains Group and related companies with MarketBeat.com's FREE daily email newsletter.
